Stock-Based Compensation (Notes)

3 Months Ended

Mar. 31, 2020

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-based compensation awards granted by our Board of Directors for the three months ended March 31, 2020 and 2019 were as follows:



	For the Three Months Ended March 31,
	2020	2019
Award type:
Stock options	298,000	157,000
Deferred share units	12,552	280
Restricted stock units	309,389	181,905

In the three months ended March 31, 2020 and 2019, we recognized $0.4 million and $0.3 million, respectively, in stock-based compensation expense. A majority of the expense, $0.3 million and $0.2 million respectively, was recorded as selling and administrative expense in the Consolidated Statement of Operations, with the remaining expenses incurred as cost of sales.

As of March 31, 2020, unrecognized compensation cost related to non-vested stock options, deferred share units and restricted stock units was $9.5 million, which will be recognized over the remaining weighted average life of 4.0 years.

Stock Option, Deferred Share Unit and Restricted Stock Unit awards activity under the Omnibus Equity Incentive Plan for the three months ended March 31, 2020 was as follows:

Stock options



	Number of Shares		Weighted- Average Exercise Price
Outstanding unvested as of December 31, 2019	931,658		15.06
Granted	298,000		9.01
Vested	(23,800	)	13.73
Forfeited	(141,960	)	14.87
Outstanding unvested as of March 31, 2020	1,063,898		13.42

Deferred Share Unit and Restricted Stock Unit awards



	Number of Shares		Weighted- Average Grant Date Fair Value
Outstanding unvested as of December 31, 2019	282,716		12.83
Granted	321,941		9.02
Vested	(42,035	)	11.90
Forfeited	(43,734	)	12.27
Outstanding unvested as of March 31, 2020	518,888		10.59